Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nela, Váňová"'
Autor:
Hana Bavlovič Piskáčková, Hana Jansová, Jan Kubeš, Galina Karabanovich, Nela Váňová, Petra Kollárová-Brázdová, Iuliia Melnikova, Anna Jirkovská, Olga Lenčová-Popelová, Jaroslav Chládek, Jaroslav Roh, Tomáš Šimůnek, Martin Štěrba, Petra Štěrbová-Kovaříková
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract The bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 has been previously identified as a more potent analog of dexrazoxane (ICRF-187), a drug used in clinical practice against anthracycline cardiotoxicity. However, the poor aqueous s
Externí odkaz:
https://doaj.org/article/5b4e58f79de6467488f64f6509b130b3
Autor:
Jaroslav Roh, Magdalena Holeckova, Michaela Adamcova, Petra Kollárová-Brázdová, Galina Karabanovich, Olga Lenčová-Popelová, Martin Štěrba, Jan Kubes, Petra Štěrbová-Kovaříková, Tomáš Šimůnek, Anna Jirkovská, Júlia Kocúrová-Lengvarská, Nela Váňová, Yvona Mazurová
Publikováno v:
Clinical Science. 135:1897-1914
The anthracycline (ANT) anticancer drugs such as doxorubicin or daunorubicin (DAU) can cause serious myocardial injury and chronic cardiac dysfunction in cancer survivors. A bisdioxopiperazine agent dexrazoxane (DEX) has been developed as a cardiopro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8760be59d95d5e93cbf6c9adb8d80479
https://doi.org/10.1042/cs20210311
https://doi.org/10.1042/cs20210311
Autor:
Rafael Doležal, David Herman, Petr Bzonek, Lukáš Prchal, Marie Vajrychová, Nela Váňová, Alžběta Dlabková, Daniel Jun
Publikováno v:
Military Medical Science Letters. 89:126-141
S ohledem na udalosti poslednich let neni riziko vojenskeho ci teroristickeho zneužiti vysoce toxických latek vcetně zakazaných bojových otravných latek zanedbatelne. Katedra toxikologie a vojenske farmacie Fakulty vojenskeho zdravotnictvi Univ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8c8eab7e64b8bc2d689fe0e073be35b
https://doi.org/10.31482/mmsl.2020.011
https://doi.org/10.31482/mmsl.2020.011
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 206
At present, therapeutic drug monitoring is the standard in pharmacotherapy using medications with a narrow therapeutic index or showing serious adverse effects, such as in the case of ibrutinib. A technique commonly used for this purpose is liquid ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7cd6796056680492da44dc5305ac6c4
https://pubmed.ncbi.nlm.nih.gov/34555634
https://pubmed.ncbi.nlm.nih.gov/34555634
Autor:
Hana Bavlovič Piskáčková, Petra Štěrbová-Kovaříková, Elisabeth Leere Øiestad, Stig Pedersen-Bjergaard, Júlia Lengvarská, Nela Váňová
Publikováno v:
Bavlovič Piskáčková, H, Øiestad, E L, Váňová, N, Lengvarská, J, Štěrbová-Kovaříková, P & Pedersen-Bjergaard, S 2021, ' Electromembrane extraction of anthracyclines from plasma : Comparison with conventional extraction techniques ', Talanta, vol. 223, 121748 . https://doi.org/10.1016/j.talanta.2020.121748
Electromembrane extraction (EME) of the polar zwitterionic drugs, anthracyclines (ANT, doxorubicin, daunorubicin and its metabolite daunorubicinol), from rabbit plasma was investigated. The optimized EME was compared to conventional sample pretreatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3c94a8a4b9e4a792fa9c9b38f981dc3
http://hdl.handle.net/10852/92169
http://hdl.handle.net/10852/92169
Autor:
Zdeněk Turek, Aleš Kohout, Jiří Kotek, Věra Radochová, Nela Váňová, David Astapenko, Jiří Páral, Ondřej Malý, Radomír Hyšpler, Ján Zajak, Daniel Jun
Publikováno v:
Ann Transl Med
Background: Liver resection is a surgical procedure associated with a high risk of hepatic failure that can be fatal. One of the key mechanisms involves ischemia-reperfusion damage. Building on the well- known positive effects of hydrogen at mitigati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf4a8c68718ff1d41476c88fc6f359a
https://europepmc.org/articles/PMC6989999/
https://europepmc.org/articles/PMC6989999/
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 206:114366
At present, therapeutic drug monitoring is the standard in pharmacotherapy using medications with a narrow therapeutic index or showing serious adverse effects, such as in the case of ibrutinib. A technique commonly used for this purpose is liquid ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0d227010442d133f770f5c9f154f16b
https://doi.org/10.1016/j.jpba.2021.114366
https://doi.org/10.1016/j.jpba.2021.114366